|
Vol. 33 Nš 10 |
Lat. Am. J. Pharm. 33 (10): 1585-1760 (2014) |
REGULAR ARTICLES |
|
|
Ketoconazole-Loaded Poly(ε-Caprolactone) Nanocapsules for Improved Antifungal Activity Against Candida spp. *
FUENTEFRIA A.M., JESUS R.S., BACK P.I., OLIVEIRA T.V., KNECHT H. & KÜLKAMP-GUERREIRO I.C. (1589)
|
|
|
|
Spectroscopic Investigation for Altered Interaction of Five Isoquinoline Alkaloids in Rhizoma Coptidis with Bovine Serum Albumin *
YANG X., ZHAO Y., ZHANG Y., MIAO Q., MIAO P., SU J., XUE B. & ZHANG Y. (1596)
|
|
|
|
Limitations of Microdialysis in Measuring Unbound Drug Concentrations in the Brain *
LU X., LIU W., GUO J., BU H., LIN J.H. & LIN F. (1609)
|
|
|
|
Experimental Study of Fasudil on the Myocardial Hypertrophy of the Transverse Aortic Constriction in Rats *
LI L., SHANG H., ZHANG C., TAO H. & CHENG J. (1618)
|
|
|
|
Effects of Acacia Grades, Oil Types and Preparation Methods on the Formation and Stability of Oral Emulsions *
BOONME P., JANGWANG A., MANEENUAN D. & YOTSAWIMONWAT S. (1624)
|
|
|
|
Gold-Catalyzed Synthesis and In Vitro Antimicrobial Bioevaluation of Novel Steroidal Oxazoles *
WANG F., LI L., LIU M. SUN H. & XIANG J. (1631)
|
|
|
|
Safety, Tolerability and Pharmacokinetics of L-3-N-Butylphthalide Sodium Chloride Injection in Healthy Chinese Subjects *
WANG M., ZHANG Q., PAN J., SHI A., HUA W., ZHU Y., XU H. & MENG Z. (1637)
|
|
|
|
Drug Utilization Study of Methotrexate Injectable Solution: a Focus on Setting of Administration *
GOMES ROSA C.C. & GUIMARÃES LIMA M. (1644)
|
|
|
|
Assessment of Physicochemical Properties of Solid-Dispersed Meloxicam Tablets Compared with Commercial Product *
MAHROUS G.M., SHAZLY G.A., EL-BADRY M., AUDA S.H. & SHAKEEL F. (1649)
|
|
|
|
Physical Stability, Rheological Analysis and Antioxidant Study of Cetyl Dimethicone Copolyol Based Cosmetic Water-In-Oil Emulsions *
WAQAS M.K., AKHTAR N., JAMIL Q.A., IJAZ S., KHAN H.M. & MURTAZA G. (1655)
|
|
|
|
Pharmacokinetic Characterization of Ginsenoside Rd, an Ulcerative Colitis Targeted-Therapy Candidate, in Gastrointestinal Tract In Vivo by HPLC *
LIU X., YANG W., HAN W., YAN S., LIU S., LI H., CHEN J., ZHANG S., CHEN X., GAO M. & WU Y. (1662)
|
|
|
|
Biophysical Study on the Interaction of Dexmedetomidine and Serum Protein *
ZHU Y., LIU G., LIU A. & YU L. (1669)
|
|
|
|
Evaluation of the Precipitation Characteristics of Ertapenem, Tigecycline, Colistin, Daptomycin, Vancomycin and Teicoplanin *
HANCI V., BOZTAŞ N., ÖMÜR D., ÖZBILGIN Ş., & HANCI S.Y. (1678)
|
|
|
|
Application of Infrared Images of Objects with Extreme Temperature Difference for the Structural Elucidation of Drug Molecules *
DING D., FANG K., HE M., YU H., QIAN K. & LIU B. (1684)
|
|
|
|
Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis *
YAO D., CHEN Z., PAN W., XU X. & LAN M. (1690)
|
|
|
|
A Simple HPLC Method for the Determination of Fluconazole in Human Plasma and Application to a Pharmacokinetic Study *
YUAN S., SONG L., ZHENG L., LI Y., QIU J. & HOU L. (1699)
|
|
|
|
Preparation of Ketoprofen/Lansoprazole Matrix Sustained-Release Pellets and In Vitro Evaluation *
LONG F., TAN M.G., WANG S., ZENG H.C., LUO X.H., ZHONG H. & LUO Y.H. (1704)
|
|
|
|
Medication Use by Elderly Residents in Long-Term Care Facilities *
GANASSIN A.R., MATOS V.T.G. de, PINA I.M., SOUZA A.S. de & TOFFOLI-KADRI M.C. (1711)
|
|
|
SHORT COMMUNICATIONS |
|
|
Pharmacokinetic Interaction between Lapatinib and Sorafenib Following Single and Co-Oral Administration in Rats *
ZHOU Y., WANG S., GENG P., ZHANG Q. & MA J. (1718)
|
|
|
|
Pharmacokinetic Interaction Study between Imatinib with Sorafenib in Rats *
WANG S., ZHOU Y., GENG P., ZHANG Q. & WEN C. (1723)
|
|
|
|
Podophyllotoxin-Ketoconazole Interaction Prediction by Molecular Docking Method *
HU W. & ZHOU W. (1728)
|
|
|
|
Therapeutic Window Alteration of Irinotecan by Ginsenosides *
XING X., WANG P., SUN X. & LI X. (1731)
|
|
|
|
Generation of Allodynia in Mechanical Pain and Related Mechanism *
MENG X. & YUE S. (1735)
|
|
|
|
Degree of Hermeticity of a Monitored Dosage System: Implications for the Quality of Medicines and Patient Safety *
LOSCERTALES H.R., MODAMIO P., BRAZA A., TOBARUELA G., LASTRA C.F. & MARIŅO E.L. (1739)
|
|
|
|
Determination of Pridinol Mesylate Injection by RP-HPLC *
ZENG H., JIANG C., LUO X., WANG S., TAN M., LONG F. & LUO Y. (1743)
|
|
|
|
Drug-Drug Interaction between Lung Cancer Therapeutic Drug Lupeol and Anti-HIV Drug Zidovudine *
LV D., JIANG Z., & YU Q. (1749)
|
|
|
|
Gomisin J Affects the Therapeutic Role of Irinotecan towards Glioma through Alteration of its Therapeutic Index *
ZHAO Z., CHEN M., CHEN P., XIE Z., & ZHANG J. (1752)
|
|
|
|
Inhibition of Deoxypodophyllotoxin (DPT) Towards Metabolism of Irinotecan Limits the Development of Deoxypodophyllotoxin as Anti-Tumor Drug *
ZHANG L.,WANG G., LIU X.,LI X., SHI C. & LIU G. (1755)
|
|
|
|
Amplication Influence of Deoxyschizandrin Towards Adverse Effect of Glioma Therapeutic Drug Irinotecan *
WANG G., SU J., SUN L., QIAO S., LI Z., NING B., & LI X. (1758)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|